Status | Study |
Completed |
Study Name: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2011-08-31 Interventions: Drug: cyclophosphamide Given I |
Terminated |
Study Name: Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate Condition: Accelerated Phase Chronic Myelogenous Leukemia Chronic Myelogen Date: 2011-08-30 Interventions: Drug: dasatinib Given PO |
Completed |
Study Name: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2010-11-02 Interventions: Biological: palifermin Given I |
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Leukemias Date: 2010-10-29 Interventions: Drug: Akt inhibitor MK2206 Giv |
Completed |
Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2010-08-05 Interventions: Drug: busulfan Given orally |
Completed |
Study Name: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myel Date: 2010-08-03 Interventions: Procedure: umbilical cord blood transplantation |
Terminated |
Study Name: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymp Date: 2010-02-24 Interventions: Drug: plerixafor Given SC |
Terminated |
Study Name: Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia Condition: Chronic Myeloid Leukemia Date: 2009-05-06 Interventions: Drug: Dasatinib (Sprycel) 100mg of Dasatinib will be administered as tablets, by mouth, once a day (or t |
Withdrawn |
Study Name: Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia Condition: Leukemia, Myeloid, Chronic Date: 2008-08-07 Interventions: Biological: Ipilimumab IV Solution, IV, 10 mg/kg, (if dose reduction necessary at 3 mg/kg), Every three |
Completed |
Study Name: Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML Condition: Myeloid Leukemia, Chronic, Accelerated Phase Leukemia, Lymphoblastic, Acute, Philadelphia-Po Date: 2005-07-21 Interventions: Drug: dasatinib Tablets, Oral, |